» Articles » PMID: 36218146

CT and Clinical Features for Distinguishing Endophytic Clear Cell Renal Cell Carcinoma from Urothelial Carcinoma

Overview
Date 2022 Oct 11
PMID 36218146
Authors
Affiliations
Soon will be listed here.
Abstract

PURPOSE We aimed to characterize the clinical and multiphase computed tomography (CT) features of the distinguishing endophytic clear cell renal cell carcinoma (ECCRCC) from endophytic renal urothelial carcinoma (ERUC). METHODS Data from 44 patients (35 men and 9 women) with ECCRCC and 21 patients (17 men and 4 women) with ERUC were retrospectively assessed. The mean patient age was 55 years (48.25- 59.50 years) and 68 years (63.00-73.00 years), respectively. Univariate and multivariate logistic regression analyses were performed to determine independent predictors for ECCRCC and to construct a predictive model that comprised clinical and CT characteristics for the differential diagnosis of ECCRCC and ERUC. Differential diagnostic performance was assessed using the area under the receiver operating characteristic curve (AUC). RESULTS The independent predictors of ECCRCC were heterogeneous enhancement (odds ratio [OR]=0.027, P=.005), hematuria (OR for gross hematuria=53.995, P=.003; OR for microscopic hematuria=31.126, P = .027), and an infiltrative growth pattern (OR=24.301, P = .022). The AUC of the predictive model was 0.938 (P < .001, sensitivity=84.10%, specificity=95.20%), which had a better diagnostic performance than heterogeneous enhancement (AUC=0.766, P=.001, sensitivity=81.82%, specificity=71.43%), hematuria (AUC=0.786, P < .001, sensitivity=81.82%, specificity=66.67%), and infiltrative growth pattern (AUC=0.748, P=.001, sensitivity=90.48%, specificity=59.09%). CONCLUSION The independent predictors, as well as the predictive model of CT and clinical characteristics, may assist in the differential diagnosis of ECCRCC and ERUC and provide useful information for clinical decision-making.

Citing Articles

CT findings and clinical characteristics in distinguishing renal urothelial carcinoma mimicking renal cell carcinoma from clear cell renal cell carcinoma.

Chen X, Feng X, Chen Y, Huang F, Long L BMC Urol. 2024; 24(1):4.

PMID: 38172791 PMC: 10765735. DOI: 10.1186/s12894-023-01393-5.

References
1.
Shinagare A, Davenport M, Park H, Pedrosa I, Remer E, Chandarana H . Lexicon for renal mass terms at CT and MRI: a consensus of the society of abdominal radiology disease-focused panel on renal cell carcinoma. Abdom Radiol (NY). 2020; 46(2):703-722. PMC: 7889755. DOI: 10.1007/s00261-020-02644-x. View

2.
Jiang J, Chen Y, Zhou Y, Zhang H . Clear cell renal cell carcinoma: contrast-enhanced ultrasound features relation to tumor size. Eur J Radiol. 2008; 73(1):162-7. DOI: 10.1016/j.ejrad.2008.09.030. View

3.
Hill A . THE ENVIRONMENT AND DISEASE: ASSOCIATION OR CAUSATION?. Proc R Soc Med. 1965; 58:295-300. PMC: 1898525. DOI: 10.1177/003591576505800503. View

4.
Jung S, Kim S, Cho J . A comparison of the use of contrast media with different iodine concentrations for multidetector CT of the kidney. Korean J Radiol. 2011; 12(6):714-21. PMC: 3194776. DOI: 10.3348/kjr.2011.12.6.714. View

5.
Shariat S, Favaretto R, Gupta A, Fritsche H, Matsumoto K, Kassouf W . Gender differences in radical nephroureterectomy for upper tract urothelial carcinoma. World J Urol. 2010; 29(4):481-6. DOI: 10.1007/s00345-010-0594-7. View